France: OSE Immunotherapeutics enters a loan agreement of up to €25 million with the EIB
This loan will further support the progress and expansion of OSE Immunotherapeutics’ lead clinical development programs in diseases with high unmet medical needs, Divided into three tranches including two tranches…
